Posts tagged •Pharmacy Benefit Managers.
Blogs
7 minute read
Over the past week, the White House administration (the “Administration”) has issued two documents addressing drug pricing. First, on February 9, 2018, the White House’s Council of Economic Advisers released a white paper titled “Reforming Biopharmaceutical Pricing at Home and Abroad” (the “White Paper”). Second, on February 12, 2018, the Administration issued its 2019 Budget Proposal (“2019 Budget”).
Whereas the recommendations set forth in the White Paper are more conceptual or exploratory, the 2019 Budget purportedly reflects the ...
Blog Editors
Recent Updates
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Reporting Requirements”
- Is Your Product Ready to Be Listed? What the Dietary Supplement Listing Act of 2026 Means for Your Business
- New York’s Food Safety and Chemical Disclosure Act: A State-Level Overhaul of GRAS Regulation
- Fighting Fire with Fire: Project Glasswing and AI-Powered Cyber Defense in Health Care, Financial Health and Other Critical Infrastructure
- Microsoft Copilot Health: Another Player In AI-Driven Healthcare